Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of [14C]GB491 on Mass Balance and Biotransformation in Chinese Male Healthy Subjects

NCT05860582 is registered in ClinicalTrials.gov with Genor Biopharma Co., Ltd. as lead sponsor.

NCT NCT05860582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05860582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of [14C]GB491 on Mass Balance and Biotransformation in Chinese Male Healthy Subjects
Lead sponsor
Genor Biopharma Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
September 14, 2022
Completion date
November 14, 2022
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, nonsmall cell lung cancer